You are here

Novo Nordisk

Novo Nordisk gives hiring update on 700 jobs pledge, breaks ground on Clayton facility

Bizjournals.com

Mon, 03/28/16 - 06:53 pm

drug manufacturing

Why ViiV Healthcare leads the pharma industry in corporate reputation

BioPharma Dive

Wed, 03/23/16 - 04:23 pm

ViiV Healthcare

Novo Nordisk Follows Eli Lilly as Worthy Rival to Merck in Diabetes

Bidness, ETC

Tue, 03/8/16 - 10:14 am

Express Scripts unimpressed by insulin data on Novo's Tresiba

BioPharma Dive

Thu, 03/3/16 - 10:41 am

Express Scripts

Novo Nordisk notches another phase 3 success for GLP-1 drug

BioPharma Dive

Fri, 02/26/16 - 10:18 am

Novo Nordisk's weekly diabetes drug goes 5-for-5 in Phase III

Fierce Biotech

Thu, 02/25/16 - 09:58 am

How Much Does Novo Spend on Its Pipeline?

Yahoo/Market Realist

Tue, 02/23/16 - 05:49 pm

FDA sets LixiLan decision date for Sanofi-Novo diabetes showdown; Eylea could outshine Bayer's sales forecasts, analyst predicts

Fierce Pharma

Mon, 02/22/16 - 06:08 pm

How Tresiba and Xultophy Will Drive Novo’s Performance

Yahoo/Market Realist

Fri, 02/19/16 - 10:13 am

Why Novo Nordisk Fell after Its 4Q15 Earnings Release

Yahoo/Market Realist

Tue, 02/9/16 - 09:15 am

How Novo’s Diabetes and Obesity Care Segment Performed in 4Q15

Yahoo/Market Realist

Mon, 02/8/16 - 09:29 pm

Insulin wars heat up as Novo's Tresiba bests Lantus in major safety outcomes trial

BioPharma Dive

Thu, 02/4/16 - 09:27 am

Novo Nordisk outstrips rivals with 8% growth, but lower profits target spooks investors

Fierce Pharma

Wed, 02/3/16 - 05:44 pm

Marketing challenges remain in crowded metabolic market

Medical Marketing and Media

Tue, 01/26/16 - 09:16 pm

Novo Nordisk rolls out long-awaited Tresiba, aiming for blockbuster market share

Fierce Pharma

Tue, 01/26/16 - 12:36 pm

Novo Nordisk eyes the future, expands presence in Iran as sanctions lift

BioPharma Dive

Fri, 01/22/16 - 09:30 pm

How Is Novo Nordisk’s Position in the Diabetes Segment?

Yahoo/Market Realist

Mon, 01/18/16 - 08:22 pm

What to Expect from Novo Nordisk’s 4Q15 Earnings

Yahoo/Market Realist

Mon, 01/18/16 - 08:22 pm

China’s diabetes boom promises $23 billion pot for drug makers

Marketwatch

Fri, 01/15/16 - 02:30 pm

Zhejiang Hisun Pharma

Novo Nordisk reinforces its commitment to fight 'urban diabetes' for the New Year

Fierce Pharma Marketing

Tue, 01/5/16 - 11:17 am

Pages